The HOMA and QUICKI indexes, and insulin and c-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children;Índice HOMA y QUICKI, insulina y péptido C en niños sanos. Puntos de corte de riesgo cardiovascular

Anales de Pediatria

Volumn 66, Issue 5, 2007, Pages 481-490

  Garcia Cuartero B ^a   Garcia Lacalle C ^a   Jimenez Lobo C ^a   Gonzalez Vergaz A ^a   Calvo Rey, C ^b   Alcazar Villar M J ^b   Diaz Martinez E ^b  

^a HOSPITAL SEVERO OCHOA   (Spain)

^b Área 9 Pediatría General   (Spain)

Author keywords

C peptide; Children; Fasting glucose; HOMA; Insulin; Insulin resistance; Pubertal stage; QUICKI; Reference values

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHEMOLUMINESCENCE; CHILD; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PUBERTY; STATISTICAL SIGNIFICANCE; ADOLESCENT; BLOOD; CARDIOVASCULAR DISEASE; HOMEOSTASIS; INFANT; PRESCHOOL CHILD; REFERENCE VALUE; RISK FACTOR;

ADOLESCENT; C-PEPTIDE; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; HOMEOSTASIS; HUMANS; INFANT; INSULIN; MALE; METABOLIC SYNDROME X; REFERENCE VALUES; RISK FACTORS;

EID: 34347380873     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13102513     Document Type: Article

References (40)

1. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: Public-health crisis, common sense cure. Lancet. 2002;360:473-82.
2. Rosenbloom AL, Joe JR, Young RS, Winter WE. Energing epidemic of type 2 diabetes in youth. Diabetes Care. 1999;22:345-54.
3. Chen W, Srinivasan SR, Elkasabany A, Berenson GS. Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (black-white) population of children, adolescents and young adults: The Bogalusa Heart Study. AM J Epidemiol. 1999;150:667-4.
4. Sasaki TM, Gray RS, Ratner RE, Currier C, Aquino A, Barhyte DY, et al. Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels. Transplantation. 1998;65:1510-2.
5. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54:2060-9.
6. Matthews DR, Hosker JP, Rudenski AS, Naylon BA, Trecher DF, Turner RC. Homeostasis model assessment insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
7. Katz A Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G. Quantitative insulin sensitivity check index: A simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-10.
8. Sobradillo B, Aguirre A, Aresti U, Bilbao A, Fernández Ramos C, Lizárraga A, et al. Curvas y Tablas de crecimiento. Instituto Investigaciones sobre crecimiento y desarrollo. Fundacion Orbegozo. Madrid: Garsi; 2004.
9. Tanner JM. Growth at adolescence (2nd ed). Nueva York: Blackwell; 1962.
10. Turkey JW. Exploratory Data Analysis. Reading: Addison-Wesley; 1977.
11. Solberg HE, Stamn D. International Federation of Clinical Chemistry, Expert Panel on Theory of Reference values. IFFC recommendations: The Theory of Reference values. Prat 4: Control of analitical variation in the production, transfer and application of references values. J Aut Chem. 1991;13:231-4.
12. Levene H. Robust tests for equality of variance. En: Olkin L, editor. Contributions to probability and statistics: Essays in honor of Harold Hotelling. Standford: University Press; 1960.
13. Serra L, Rivas L, Aranceta J, Pérez C, Saavedra P, Peña L. Obesity in children and adolescents in Spain. EnKID study results (1998-2000). Med Clin (Barc). 2003;121;725-32.
14. Albañil MR, Sánchez Martín M, De la Torre Verdú M, Olivas Domínguez A, Sánchez Méndez MY, Sanz Cuesta T. Prevalence of obesity in 14-year olds in four primary care centers. Trends in weight changes since the age of two years old. An Esp Pediatr. 2005;63;39-44.
15. Reaven G. Syndrome X. Curr Treat Options Cardiovasc Med. 2001;3:323-32.
16. Chen W, Srinivasan S, Li S, Xu J, Berenson G. Metabolic syndrome variables at low levels in childhood are beneficially associated with adulthood cardivascular risk. The Bogalusa heart study. Diabetes Care. 2005;28:126-31.
17. LeRoith D, Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care. 2001;24:588-97.
18. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med. 2002;19:527-34.
19. Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr. 2004;144:47-55.
20. Ascaso JF, Pardo S, Real J, Lorente R, Priego A, Carmena R. Diagnosing insulin resistance by symple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26:3320-5.
21. Bao W, Srinivasan SR, Berenson GS. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation. 1996;93:54-9.
22. Jessup A, Harrell S. The metabolic syndrome: Look for it in children and adolescents, too. Clinical Diabetes. 2005;23:26-35.
23. Kashiwabara H, Inaba M, Maruno Y, Morita T, Awata T, Negishi K, et al. Insulin levels during fasting and the glucose tolerance test and HOMA's index predict subsequent development of hypertension. J Hipertens. 2000;18:83-8.
24. Eschwege E, Richard JL, Thibult N, Ducimetiere P, Warnet JM, Claude JR, et al. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris prospective study, ten years later. Horm Metab Res Suppl. 1985;15:41-6.
25. Francois A, Maumus S, Vicent-Viry M, Gueguen R, Siest G, Visvikis S. Age and sex-related reference values for serum insulin concentration and its biological determinants in a french healthy population. The STANISLAS cohort. Clin Chem Lab Med. 2004;42:1140-9.
26. Moran A, Jacobs D, Steinberger J, Hong Ching-Hong, Prineas R, Luepker R, et al. Insulin resistance during puberty. Results from clamp studies in 357 children. Diabetes. 1999;48:2039-44.
27. Allard P, Delvin E, Paradis G, Hanley J, O'Loughlin J, Lavallée C, et al. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance sample of Quebec children and adolescents. Clinical Chemistry. 2003;49:644-9.
28. Wennlof A, Yngve A, Nilsson TK, Sjostrom M. Serum lipids, glucose and insulin levels in healthy schoolchildren aged 9 and 15 years from central Sweden: reference values in relation to biological, social and lifestyle factors. Scand J Clin Lab Invest. 2005;65:65-76.
29. Arslalian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: Is "syndrome X" present ? J Clin Endocrinol Metab. 1996;81:1058-62.
30. Ascaso JF, Romero P, Real J, Priego A, Valdecabres C, Carmena R. Insulin resistanse cuantification by fasting insulin plasa values and HOMA index in a non-diabetic population. Med Clin (Barc). 2001;117:530-3.
31. Ratzmann KP, Strese J, Kohnert KD, Jahr D, Michaelis D. Age-dependent relationship of fasting C-peptide concentration and insulin secretion in non-obese subjects with normal glucose tolerance. Exp Clin Endocrinol. 1986;88:57-63.
32. Heinz E, Holl RW. Test of beta cell function in childhood and adolescence. En: Ranke MB, editor. Diagnostic of endocrine function in children and adolescents. Basel: Karger; 2003. p. 318-38.
33. Carel JC, Boitard C, Bougneres DF. Decreased insulin response to glucose in islet-cell antibody negative siblings of type 1 diabetes children. J Clin Invest. 1993;92:509-13.
34. Bonora E, Kiechll S, Willeit J. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998;47:1643-9.
35. Haffner SM, González C, Miettinen H. A prospective analisis of the HOMA model. Diabetes Care. 1996;19:1138-41.
36. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yacizi C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assesing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:500-3.
37. Conwell LS, Trost S, Brown W, Batch J. Indexes of insulin resistance and secretion in obese children and adolescents. Diabetes Care. 2004;27:314-9.
38. Raikkonen K, Mattews KA, Salomon K. Hostility predicts metabolic syndrome risk factors in children and adolescents. Health Psychol. 2003;22:279-86.
39. Tresaco B, Bueno G, Pineda J, Moreno LA, Garragorri JM, Bueno M. HOMA index cut-off values to identify the metabolic syndrome in children. J Physiol and Biochem. 2005;61:381-8.
40. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab. 2002;87:144-7.